Nomura Asset Management International’s Nektar Therapeutics NKTR Stock Holding History

Nomura Asset Management International’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19M	Buy	+17,092	New	+$1.25M	﹤0.01%	1178

Other funds holding NKTR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nomura Asset Management International's NKTR Position: Q2 2026 in Review

Nomura Asset Management International opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 17,092 shares worth $1.19M. The stake represents ﹤0.01% of the portfolio and ranks #1178 among its holdings.

239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

Nomura Asset Management International held 17,092 shares of Nektar Therapeutics worth $1.19M as of Q2 2026.
Nektar Therapeutics was a new Nomura Asset Management International position in Q2 2026.
Nektar Therapeutics made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1178 holding.
239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.